Companies House 11725908 2025-03-31 2025-03-31 2024-04-01 false iso4217:GBP xbrli:pure 11725908 2023-04-01 2024-03-31 11725908 2025-03-31 11725908 2024-04-01 2025-03-31 11725908 2024-03-31 11725908 curr:PoundSterling 2024-04-01 2025-03-31 11725908 uk-bus:CompanyLimitedByGuarantee 2024-04-01 2025-03-31 11725908 uk-bus:FRS102 2024-04-01 2025-03-31 11725908 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11725908 uk-bus:FullAccounts 2024-04-01 2025-03-31 11725908 uk-bus:RegisteredOffice 2024-04-01 2025-03-31 11725908 uk-bus:Director1 2024-04-01 2025-03-31 11725908 uk-bus:Director2 2024-04-01 2025-03-31 11725908 uk-bus:Director3 2024-04-01 2025-03-31 11725908 uk-bus:Director4 2024-04-01 2025-03-31 11725908 uk-bus:Director5 2024-04-01 2025-03-31 11725908 uk-bus:Director6 2024-04-01 2025-03-31 11725908 uk-bus:Director7 2024-04-01 2025-03-31 11725908 uk-bus:Director8 2024-04-01 2025-03-31 11725908 uk-bus:Director9 2024-04-01 2025-03-31 11725908 uk-bus:Director10 2024-04-01 2025-03-31 11725908 uk-bus:Director11 2024-04-01 2025-03-31 11725908 uk-bus:Director12 2024-04-01 2025-03-31 11725908 uk-bus:Director13 2024-04-01 2025-03-31 11725908 uk-bus:Director14 2024-04-01 2025-03-31 11725908 uk-bus:Director15 2024-04-01 2025-03-31 11725908 uk-bus:Director16 2024-04-01 2025-03-31 11725908 uk-bus:Director17 2024-04-01 2025-03-31 11725908 uk-bus:Director18 2024-04-01 2025-03-31 11725908 uk-bus:Director19 2024-04-01 2025-03-31 11725908 uk-bus:Director20 2024-04-01 2025-03-31 11725908 uk-bus:Director21 2024-04-01 2025-03-31 11725908 uk-bus:CompanySecretary1 2024-04-01 2025-03-31 11725908 core:AfterOneYear 2025-03-31 11725908 core:AfterOneYear 2024-03-31 11725908 core:WithinOneYear 2025-03-31 11725908 core:WithinOneYear 2024-03-31 11725908 core:WithinOneYear 2024-04-01 2025-03-31 11725908 core:AfterOneYear 2025-03-31 11725908 core:AfterOneYear 2024-03-31 11725908 core:AfterOneYear 2024-04-01 2025-03-31 11725908 core:ShareCapital 2025-03-31 11725908 core:ShareCapital 2024-03-31 11725908 core:SharePremium 2025-03-31 11725908 core:SharePremium 2024-03-31 11725908 core:OtherReservesSubtotal 2025-03-31 11725908 core:OtherReservesSubtotal 2024-03-31 11725908 core:RevaluationReserve 2025-03-31 11725908 core:RevaluationReserve 2024-03-31 11725908 core:RetainedEarningsAccumulatedLosses 2025-03-31 11725908 core:RetainedEarningsAccumulatedLosses 2024-03-31 11725908 1 2024-04-01 2025-03-31 11725908 2 2024-04-01 2025-03-31 11725908 3 2024-04-01 2025-03-31 11725908 core:LandBuildings 2024-04-01 2025-03-31 11725908 core:LandBuildings 2025-03-31 11725908 core:LandBuildings 2023-04-01 2024-03-31 11725908 core:LandBuildings 2024-03-31 11725908 core:PlantMachinery 2024-04-01 2025-03-31 11725908 core:PlantMachinery 2025-03-31 11725908 core:PlantMachinery 2023-04-01 2024-03-31 11725908 core:PlantMachinery 2024-03-31 11725908 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 11725908 core:FurnitureFittingsToolsEquipment 2025-03-31 11725908 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 11725908 core:FurnitureFittingsToolsEquipment 2024-03-31 11725908 core:OfficeEquipment 2024-04-01 2025-03-31 11725908 core:OfficeEquipment 2025-03-31 11725908 core:OfficeEquipment 2023-04-01 2024-03-31 11725908 core:OfficeEquipment 2024-03-31 11725908 core:Vehicles 2024-04-01 2025-03-31 11725908 core:Vehicles 2025-03-31 11725908 core:Vehicles 2023-04-01 2024-03-31 11725908 core:Vehicles 2024-03-31 11725908 core:NetGoodwill 2024-04-01 2025-03-31 11725908 core:NetGoodwill 2025-03-31 11725908 core:NetGoodwill 2023-04-01 2024-03-31 11725908 core:NetGoodwill 2024-03-31 11725908 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 11725908 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 11725908 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 11725908 core:IntangibleAssetsOtherThanGoodwill 2024-03-31

# MULTIPLE SCLEROSIS UNION CIC

## Company limited by guarantee

## Company Registration Number:
11725908 (England and Wales)

## Unaudited statutory accounts for the year ended 31 March 2025

## Period of accounts

## Start date: 1 April 2024

## End date: 31 March 2025

# MULTIPLE SCLEROSIS UNION CIC

## Contents of the Financial Statements

for the Period Ended 31 March 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# MULTIPLE SCLEROSIS UNION CIC

Directors' report period ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Directors

The directors shown below have held office during the whole of the period from
1 April 2024 to 31 March 2025

Margaret Giller
Michael Giller
Doris Jiagge
Leslie Hays Rees
James Michael MCPETRIE

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
7 September 2025

And signed on behalf of the board by:
Name: Margaret Giller
Status: Director

# MULTIPLE SCLEROSIS UNION CIC

## Profit And Loss Account

for the Period Ended 31 March 2025

| 2025 | 2024
--- | --- | ---
| £ | £
Turnover: | 28,656 | 33,471
Cost of sales: | ( 136 ) | ( 6,310 )
Gross profit(or loss): | 28,520 | 27,161
Administrative expenses: | ( 36,262 ) | ( 25,669 )
Operating profit(or loss): | (7,742) | 1,492
Profit(or loss) before tax: | (7,742) | 1,492
Tax: |  | ( 283 )
Profit(or loss) for the financial year: | (7,742) | 1,209

# MULTIPLE SCLEROSIS UNION CIC

## Balance sheet

As at 31 March 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Current assets
Cash at bank and in hand: |  | 24,246 | 32,271
Total current assets: |  | 24,246 | 32,271
Creditors: amounts falling due within one year: | 3 | ( 6,308 ) | ( 6,591 )
Net current assets (liabilities): |  | 17,938 | 25,680
Total assets less current liabilities: |  | 17,938 | 25,680
Total net assets (liabilities): |  | 17,938 | 25,680
Members' funds
Profit and loss account: |  | 17,938 | 25,680
Total members' funds: |  | 17,938 | 25,680

The notes form part of these financial statements

# MULTIPLE SCLEROSIS UNION CIC

## Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 7 September 2025
and signed on behalf of the board by:

Name: Margaret Giller
Status: Director

The notes form part of these financial statements

# MULTIPLE SCLEROSIS UNION CIC

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

  Other accounting policies

  Taxation The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Financial instruments A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. 4.Limited by guarantee The members’ liability is limited to the amount they agree to contribute to the company’s assets if it is wound up.

# MULTIPLE SCLEROSIS UNION CIC

## Notes to the Financial Statements

for the Period Ended 31 March 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# MULTIPLE SCLEROSIS UNION CIC

## Notes to the Financial Statements

for the Period Ended 31 March 2025

## 3. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Trade creditors | 6,308 | 6,308
Taxation and social security |  | 283
Total | 6,308 | 6,591

# COMMUNITY INTEREST ANNUAL REPORT

### MULTIPLE SCLEROSIS UNION CIC

### Company Number: 11725908 (England and Wales)

### Year Ending: 31 March 2025

Company activities and impact

The company is supporting the people with Multiple Sclerosis that live within the borough of Barnet, helping towards the funding of the training of MS Nurses. MS Nurses are in very short supply. We also signpost MS sufferers to any other help that is available in the borough.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
7 September 2025

And signed on behalf of the board by:
Name: Margaret Giller
Status: Director